Skip to main content

Cancer

Cancer Center at Illinois announces 2022 cancer research grant recipients

The Cancer Center at Illinois is proud to announce the selection of nine interdisciplinary cancer research projects, involving multiple MCB faculty members, designed by University of Illinois Urbana-Champaign faculty to be funded by Cancer Center at Illinois (CCIL) developmental grant awards.

New therapeutic target identified for triple-negative breast cancer

Breast cancer is categorized into three major subtypes: hormone receptor-positive, HER2-positive, and triple-negative. Although there are targeted therapeutic approaches for the first two, there are limited options for triple negative-breast cancer patients. In a new study, researchers have...

Light-activated technique helps bring cell powerhouses back into balance

University of Illinois biochemistry professor Kai Zhang and collaborators developed a technique using light to regulate mitochondria, the energy-producing powerhouses inside cells. The technique could address mitochondrial diseases and cancer.

Prasanth lab uncovers new insights into the role of Orc6 in the maintenance of genome integrity

New research from Supriya Prasanth’s lab at the University of Illinois provides tremendous insight into the role of the smallest subunit of the human ORC, Orc6. Although the ORC is conserved in all eukaryotes, Orc6 is the most evolutionarily diverged. In a recent study published in PNAS, the...

Exploring RNA’s Binding Role in Liver Disease and Cancer

Kalsotra’s research has focused on RNA, the workhorse cousin of DNA, which makes up the genetic instructions for living things. RNA is often viewed as important for messaging and other functions, taking DNA’s code and transporting it to and carrying out functions in cells. It’s often taken a back...

Taking a Deep Look at Protein Structures that Contribute to Cancer

Thirteen years ago, when Lin-Feng Chen joined the Department of Biochemistry, he had his sights set on a specific protein that could both contribute to the growth of cancer and be a major factor in boosting the body’s immune system.

Harnessing and Boosting T-cells to Fight Disease

David Kranz, the Phillip A. Sharp Professor of Biochemistry in the School of Molecular and Cellular Biology, has been involved in T-cell research since working as a postdoctoral researcher at the Massachusetts Institute of Technology, involved in early discoveries about how T-cells might be used to...

MCB Faculty Help Lead the Cancer Center at Illinois in Collaborative, Interdisciplinary, and Translational Research

Several MCB faculty members are part of an exciting new campus unit known as The Cancer Center at Illinois. The Center is an interdisciplinary collaborative hub with more than 100 faculty members from departments ranging from kinesiology, human development and nutrition to electrical and computer...

Researchers determine Pol III “identity” as important regulatory mechanism and likely disease factor in cancer

Researchers at the University of Illinois Urbana-Champaign and Stanford University School of Medicine have identified a link between RNA polymerase III subunit composition and transcription, an advancement that has potential implications for future cancer research. Their findings were published in...

Meet MCB: Molecular & Integrative Physiology PhD student Hashni Epa Vidana Gamage​

Hashni Epa Vidana Gamage​ is a PhD student in the School of Molecular and Cellular Biology at the University of Illinois Urbana-Champaign. In our latest "Meet MCB" video, Hashni shares what it means to her to be a part of a lab researching ways to improve breast cancer treatment.